Dietary
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| MATERIALS AND METHODS |
|---|
|
|
|---|
Experimental Animals
All experimental procedures using laboratory animals were approved by the Vitairiver Company, Beijing, China. Male F344 rats weighing 220–280 g were used as donors, and female Lewis rats weighing 250–280 g, as recipients.
The transplanted rats included 3 groups: Lewis-to-Lewis group (n = 8); 2 groups of F344-to-Lewis (n = 10). Lewis-to-Lewis isogeneic (ISO) transplants were included as controls for nonallogeneic injury. From 2 weeks pretransplantation to the 60th day posttransplantation, the Lewis rats had been supplemented by gavage with fish oil (FO) or corn oil (CO; both from Sigma Chemical, St. Louis, MO; product number F8020), 0.6% V/W (mL per 100 g body weight). The fish oil contained EPA (139 mg/mL) and DHA (136 mg/mL). The protocol was approved by the Animal Research Committee of Nanjing University. All procedures were carried out in accordance with Principles of Laboratory Animal Care (NIH publication No. 85–23, revised 1985).
SBT
Heterotopic SBT was performed using a standard microvascular
technique.12 Donor
and recipient operations were performed under anesthesia induced with 100
mg/kg ketamine. The abdomen was opened by a midline incision under ketamine
anesthesia. The donor small bowel (jejunum-ileum) was removed after
intraluminal and intravascular irrigation with cold heparinized saline
solution (4°C). The bowel was excised with its intact vascular pedicle,
consisting of the superior mesenteric artery with an aortic cuff and the
portal vein. The graft was kept in cooled lactated Ringer's solution for 25
minutes. The recipient abdomen was opened and the graft was reperfused by
anastomosing the aortic cuff to the recipient infrarenal aorta, although the
portal vein was anastomosed to the recipient inferior vena cava. The proximal
and distal ends of the bowel were exteriorized as stomas. Animals surviving
<24 hours were considered technical failures and excluded. All of the
recipients were treated with cyclosporine A (Sandimmune; Novartis Pharmacy
Ltd, Basel, Switzerland), 5 mg/kg/d for POD 0–13, to prevent acute
rejection.
Histopathology
Sequential protocol biopsies were performed every 2 weeks from 2 to 8 weeks
after transplantation. All recipients were killed at 16 weeks
posttransplantation as ending. Sequential biopsies were performed under ether
anesthesia. Stoma was placed at a midline incision convenient for biopsy and
to alleviate the incision scar. When biopsied, the segment of intestinal open
stoma, about 2 cm length, was excised with the corresponding mesentery.
Paraffin sections 2–4 µm thick were stained with hematoxylin and
eosin stain and evaluated in a blinded manner by 2 observers.
Flow Cytometry
Epithelial cells were isolated from the recipients. In brief, the small
intestine was resected, dissected open, cut into 2- to 3-mm pieces, and rinsed
clean in 50 mL of Ca2+ and Mg2+ free HBSS at room
temperature. Tissue was then diced into <1- to 3-mm pieces, incubated with
20 mL of enzyme solution (0.1 mg/mL dispase type I and 300 U/mL collagenase
type XI; Sigma-Aldrich, St. Louis, MO) for 30 minutes with agitation at 80
cycles/min. The cell suspension was pipetted vigorously for 3 minutes and left
to sediment under gravity for 1 minute. The supernatant was collected and
added to 10 mL of DMEM +2.5% FCS with 2% sorbitol and centrifuged at 1000
x g for 2 minutes. This process was repeated until the
supernatant was clear and the pellet was well defined.
Phosphatidylserine (PS)
Rat small intestine mucosa cells were stained with propidium iodide (PI)
and FITC-labeled annexin V by using the Annexin-V-APOP kit (Alexis Co,
Switzerland) to assess cellular integrity and the externalization of PS. Cells
were washed twice in PBS and suspended in modified annexin binding buffer (10
mmol/L HEPES/NaOH, pH 7.4; 40 mmol/L NaCl; 50 mmol/L CaCl2; 1.2 M
sorbitol). Annexin V binding assays were performed according to the protocol
of Monchik et al12
in modified annexin binding buffer containing 20 µL/mL annexin reagent and
20 µg/mL PI. We measured exposed PS by treating red cells with commercially
available FITC-labeled annexin V in the presence of calcium, washing with a
calcium-containing buffer, and measuring cell-associated fluorescence in a
Becton, Dickinson FACScan flow cytometer (Ex = 488 nm; Em = 530 nm).
Acquisition and data analysis were performed by using CELLQUEST software
(Becton, Dickinson, Franklin Lakes, NJ). Ten thousand events per sample were
acquired to minimize sampling errors. Fluorescent channels and light scatter
were set at log gain. The FSC setting was at E-1 with a threshold of 36. The
SSC PMT voltage was set at 250 and the FL1 PMT voltage, at 750.
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Expression of specific gene transcripts identified within biopsy tissue was
quantified by RT-PCR. RT was performed for 50 minutes at 42°C with
Superscript II (Invitrogen, Carlsbad, CA). PCR primers were based on conserved
sequences of rat perforin 1 (NM_017330), granzyme B (NM_138517), and CI-MPR
(RNU59809). Primer design for RT-PCR was carried out with the software Primer
Express (Applied Biosystems, Foster City, CA). Amplification of the
universally expressed β-actin gene (V01217) served to confirm successful
RNA isolation and reverse transcription. Primers were designed as follows:
- perforin 1
- forward primer: CCTAAACCGGAAGCAAACGTGCAT
- reverse primer: TGTACATGCGACACTCCACTGTGT
- forward primer: CCTAAACCGGAAGCAAACGTGCAT
- granzyme B
- forward primer: ACGCAACGTCAAAGTGAAACCAGG
- reverse primer: TTTACACACAAGAGGCCCTCCAGA
- forward primer: ACGCAACGTCAAAGTGAAACCAGG
- CI-MPR (mannose 6-phosphate/insulin-like growth factor II receptor)
- forward primer: ACAGGGCTGTGCTGTAACAGATGA
- reverse primer: TGGCACTCTTCTTGCAAATGCTGG
- forward primer: ACAGGGCTGTGCTGTAACAGATGA
- β-actin
- forward primer: AGAGAAGCTGTGCTATGTTGCCCT
- reverse primer: ACTCCTGCTTGCTGATCCACATCT
- forward primer: AGAGAAGCTGTGCTATGTTGCCCT
PCR was performed in a 50-µL volume containing 2 units of Taq polymerase, 1.5 mmol/L MgCl2, and 1–2 µL of cDNA from the RT reaction. The initial denaturation step was at 94°C for 3 minutes, followed by 30 cycles of denaturation for 25 seconds at 94°C, annealing for 40 seconds at 60°C, and extension for 1 minute at 72°C. Each PCR reaction was replicated a minimum of 3 times. β-Actin expression was determined for each sample to equalize cDNA loading and permit semiquantitative comparisons between samples. PCR products were electrophoresed on a 1% agarose gel, stained with ethidium bromide, and photographed in UV light.
Statistical Analysis
Results are expressed as mean ± SD, using SPSS 11.5 for Windows.
Statistical analyses were carried out with 1-way ANOVA. Values were considered
significant at p < .05.
| RESULTS |
|---|
|
|
|---|
Body Weight and Histology
Animals undergoing transplantation lost weight during the first 3–5 days posttransplant and then began a slow recovery and increase in body weight. They regained weight and continued growing after 7–10 days posttransplantation. The difference of the mean body weights of different experimental groups was not obvious.13
We have previously described that all of the allografts demonstrated 1 or more histologic features of chronic rejection at 16 weeks. The intestine wall of allografts appeared thickened and stiff, with some peritoneal adhesion. Mesenteries showed a milky whitish surface and appeared fibrotic. Lengths of mesenteries were moderate and mildly shortened. The significant characteristics of allografts on histology were changes of villous architecture, interstitial fibrosis, leukocyte infiltration, and arteriopathy.13
Annexin V Analysis
Apoptosis occurred inevitably in allograft mucosal cells after small
intestinal transplantation. Although no rejection was detected in the
Lewis-to-Lewis group, apoptosis of mucosal cells was triggered due to the
injury of ischemia/reperfusion mechanism and the disuse atrophy. Obviously,
chronic rejection raised the apoptotic rate of CO group. The result that the
apoptosis was markedly prevented in the FO group showed the inhibiting
activity of
-3 PUFA on mucosal apoptosis induced by rejection (Figures
1 and
2).
|
|
The small intestinal transplantation of the ISO group was found to have a low apoptotic rate 3.684% ± 2.04% (mean ± SD; n = 8). This rate of the ISO control group increased significantly to 31.137 ± 5.71 (n = 10; p < .05 vs ISO group). The FO group administered rich
-3 PUFA, however, was found to have a much lower rate of apoptosis,
only 14.831 ± 3.75, p < .05 vs CO group,
suggesting that
-3 PUFA inhibited the apoptosis rate of mucosal cells
in the graft.
RT-PCR
Tissue RNA of control and transplanted biopsies was isolated and expression
of specific gene transcripts was quantified by RT-PCR. RT was performed for 50
minutes at 42°C with Superscript II. PCR was performed with the initial
denaturation step at 94°C for 3 minutes, followed by 30 cycles of
denaturation for 25 seconds at 94°C, annealing for 40 seconds at 60°C,
and extension for 1 minute at 72°C. Each PCR reaction was replicated a
minimum of 3 times. β-Actin expression was determined for each sample to
equalize cDNA loading and permit semiquantitative comparisons between samples.
The gray density of each band was compared with the band of β-actin
internal control, as showed in Figures
3,
4, and
5.
|
|
|
The granzyme B RT-PCR result was 0.0243 ± 0.005 (mean ± SD; n = 8) and 0.0872 ± 0.007 (mean ± SD; n = 10), p < .05, in the ISO group and CO group, respectively. It suggested a remarkable increase of granzyme B activation in mucosal cells when chronic rejection of the allograft took place. The value of FO group was 0.0413 ± 0.006 (mean ± SD; n = 10), which was much less than that of the CO group, p < .05, suggesting that
-3 PUFA inhibited the expression
of granzyme B in mucosal cells.
The perforin RT-PCR result was 0.144 ± 0.010 (mean ± SD; n =
8) and 0.345 ± 0.043 (mean ± SD; n = 10), p < .05,
in the ISO group and CO group, respectively. It suggested a remarkable
increase of perforin activation in mucosal cells when chronic rejection of the
allograft took place. The value of the FO group was 0.201 ± 0.021 (mean
± SD; n = 10), which was much less than that of CO group, p
< .05, suggesting that
-3 PUFA inhibited the expression of perforin
in graft mucosal cells.
The CI-MPR RT-PCR result was 0.069 ± 0.009 (mean ± SD; n = 8)
and 0.645 ± 0.057 (mean ± SD; n = 10), p < .05, in
the ISO group and CO group, respectively. It suggested a remarkable increase
of CI-MPR activation in mucosal cells when chronic rejection of the allograft
took place. The value of the FO group was 0.281 ± 0.042 (mean ±
SD; n = 10), which was much less than that of the CO group, p <
.05, suggesting that
-3 PUFA inhibited the expression of CI-MPR in
graft mucosal cells.
| DISCUSSION |
|---|
|
|
|---|
Clinical and experimental evidence showed that
-3 PUFAs have
anti-inflammatory actions in a number of inflammation-associated disease
states, including atherosclerosis, autoimmune disorders, malignancy, and
sepsis. Study on
-3 PUFA and apoptosis focused on the field of tumor
cells, and
-3 PUFA was generally reported to promote the apoptosis of
tumor cells.
-3 PUFA was demonstrated to inhibit the apoptosis of
mucosal cells in allograft small intestine in our study. Apoptosis plays a critical role in mucosal restitution after injury. Apoptosis prevents the release of cellular material (eg, lysosomal proteases) that occurs after cellular necrosis, which may lead to mucosal injury. However, exaggerated apoptosis is observed in inflamed/ulcerated areas of colonic mucosa in inflammatory bowel disease and this may impair mucosal restitution.14
Fayyazi et al15
first demonstrated the presence of a high number of apoptotic enterocytes in a
rat model of allogenic small intestinal transplantation without
immunosuppression. The authors described a positive correlation between
histologic findings of rejection and the number of apoptotic cells detected in
allografts. It was shown in our study that the apoptosis rate of mucosal cells
was as high as 31% in allograft with chronic rejection, demonstrated by
pathologic evaluation, when immunosuppression was used. The rate decreased to
14.8% in the fish oil group with administration of rich
-3 PUFA. It
suggested that
-3 PUFA depressed the rejection to allograft small
intestine, reduced the dosage of immunosuppression, and minimized the risk of
infection.
The granule-exocytosis model has evolved since its original enunciation by Henkart.16 Initially, one of the granule proteins, perforin, was thought to be the major effector of CTL-induced death. However, it then became obvious that target cells were dying through an apoptotic mechanism that involved damage of DNA.17 The factor responsible was purified and identified as a known cytotoxic cell protease, now referred to as granzyme B.18 In a complementary approach, it was shown that cells were endowed with the ability to induce membrane damage and DNA fragmentation when they were transfected to express granzyme B and perforin.19 The CI-MPR is a receptor for granzyme B on the target cell surface, and this recognition is necessary for the efficient apoptosis of target cells mediated by granule-purified granzyme B or by CTL. The modulation of the CI-MPR on the target cell surface would thus have profound repercussions on the ability of CTL to induce apoptosis by the granzyme B–mediated pathway.5
The study on granzyme/perforin pathway in apoptosis suggested that the
granzyme and perforin were activated when chronic rejection to allograft small
intestine occurred, which correlated with the increasing activity and amount
of the T cell that released granzyme and perforin toward target cells in
immunological rejection. Through perforin introduction, granzyme induced the
apoptosis of the target cells.
-3 PUFA inhibited the expression of
granzyme and perforin to suppress the apoptosis, which may be associated with
its effect on the activity and amount of T cells.
CI-MPR, expressed on the surface of cells, was of great importance in
granzyme-triggered apoptosis by introducing granzyme into the target cells, in
place of perforin. The regulation and signal transference pathway remain to be
well documented. Our study found that the CI-MPR expression increased on
mucosal cells significantly at the time of chronic rejection, which induced
granzyme into cells and accelerated the apoptosis. In the
-3 PUFA
group, however, RT-PCR demonstrated the reduction of CI-MPR expression
markedly, which may inhibit the granzyme in cells and the apoptosis
finally.
The decreasing apoptosis rate retained the mucosal barrier and prevented
the bacteria translocation. Granzyme and perforin were inhibited in
-3
PUFA group; so was CI-MPR expression, which induced granzyme into cells
without perforin.
Apoptosis induced by granzyme/perforin and CI-MPR correlated with
immunological rejection in organ allograft, and
-3 PUFA inhibited this
progression. It suggested in some studies that the apoptotic rate of mucosal
cell of the intestine correlated with the level of rejection. It suggested
that
-3 PUFA depressed the rejection to allograft small intestine,
reduced the dosage of immunosuppression, and minimized the risk of infection.
Our study suggested that
-3 PUFA suppressed the rejection to mucosal
cells of allograft at the time of chronic rejection in small intestinal
transplantation, which may be significant in increasing the surviving rate of
allograft, delaying the chronic dysfunction, and prolonging the lifetime of
both allograft and acceptor.
This work was funded by the National Basic Research Program of China (No. 2003CB515502).
Received for publication January 19, 2007. Accepted for publication July 9, 2007.
- Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol.1997; 158:4654 –4661.[Abstract]
- Woodle ES, Kulkarni S. Programmed cell death.Transplantation. 1998;66:681 –691.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Froelich CJ, Orth K, Turbov J, et al. New paradigm for lymphocyte
granule-mediated cytotoxicity: target cells bind and internalize granzyme B,
but an endosomolytic agent is necessary for cytosolic delivery and subsequent
apoptosis. J Biol Chem. 1996;271
:29073
–29079.
[Abstract/Free Full Text] - Lord SJ, Rajotte RV, Korbutt GS, Bleackley RC. Granzyme B: a natural born killer. Immunol Rev.2003; 193:31 –38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Motyka B, Korbutt G, Pinkoski MJ, et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell–induced apoptosis.Cell. 2000;103:491 –500.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- White WL, Zhang YL, Shelby J, et al. Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy. J Heart Lung Transpl.1997; 16:250 –255.[Web of Science][Medline] [Order article via Infotrieve]
- Ito H, Kasagi N, Shomori K, Osaki M, Adachi H. Apoptosis in the human allografted kidney: analysis by terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling.Transplantation. 1995;60:794 –798.[Web of Science][Medline] [Order article via Infotrieve]
- Laine J, Etelamaeki RM, Holmberg C, Dunkel L. Apoptotic cell death in human chronic renal allograft rejection. Transplantation.1997; 63:101 –105.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Nawaz S, Fennell RH. Apoptosis of bile duct epithelial cells in hepatic allograft rejection. Histopathology.1994; 25:137 –142.[Web of Science][Medline] [Order article via Infotrieve]
- James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty
acids and inflammatory mediator production. Am J Clin Nutr.2000; 71(1 Suppl):343S
–348S.
[Abstract/Free Full Text] - Calder PC, Yaqoob P, Thies F, Wallace FA, Miles EA. Fatty acids and lymphocyte functions. Br J Nutr.2002; 87(Suppl 1):S31 –S48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Monchik GJ, Russell PS. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery.1971; 70:693 –702.[Web of Science][Medline] [Order article via Infotrieve]
- Ma H, Wang J, Wang J, Li Y, Li J. Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant. 2007;11:173 –179.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Iwamoto M, Koji T, Makiyama K, Kobayashi N, Nakane PK. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol.1996; 180:152 –159.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Fayyazi A, Schlemminger R, Gieseler R, Peters JH, Radzun HJ. Apoptosis in the small intestinal allograft of the rat.Transplantation. 1997;63:947 –951.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Henkart PA. Mechanism of lymphocyte-mediated cytotoxicity.Annu Rev Immunol. 1985;3:31 –58.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD.
Purified perforin induces target cell lysis but not DNA fragmentation.J Exp Med.
1989;170:1451
–1456.
[Abstract/Free Full Text] - Masson D, Tschopp J. A family of serine esterases in lytic granules of cytolytic T lymphocytes. Cell.1987; 49:679 –685.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
- Nakajima H, Park HL Henkart PA. Synergistic roles of granzymes A
and B in mediating target cell death by rat basophilic leukemia mast cell
tumors also expressing cytolysis/perforin. J Exp Med.1995; 181:1037
–1046.
[Abstract/Free Full Text]
Journal of Parenteral and Enteral Nutrition, Vol. 32, No. 1,
12-17 (2008)
DOI: 10.1177/014860710803200112
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

-3 Polyunsaturated Fatty Acids Can Inhibit Expression of Granzyme B, Perforin, and Cation-Independent Mannose 6-Phosphate/Insulin-Like Growth Factor Receptor in Rat Model of Small Bowel Transplant Chronic Rejection



